The EU’s drug regulator, the European Medicines Agency, finds itself in the hot seat on Thursday when it will decide what to do about blood clot fears over the AstraZeneca coronavirus jab. After spending much of its existence in relative…
Read More
U.S. FDA Expands Approval of Pfizer’s Lorbrena as First-Line Treatment for ALK-Positive Metastatic Lung Cancer
NEW YORK–(BUSINESS WIRE) March 03, 2021 — The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for Lorbrena® (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase…
Read More
US new daily COVID cases at five-month low as nations try to hold off surge
The United States recorded fewer than 40,000 new daily cases of COVID-19 for the first time in five months on Thursday, a piece of promising news as countries across the globe struggle to hold off another infection surge before inoculations…
Read More
US traffic deaths spike even as pandemic cuts miles traveled
Pandemic lockdowns and stay-at-home orders kept many drivers off U.S. roads and highways last year. But those who did venture out found open lanes that only invited reckless driving, leading to a sharp increase in traffic-crash deaths across the country….
Read More
As death approaches, our dreams offer comfort and reconciliation
One of the most devastating elements of the coronavirus pandemic has been the inability to personally care for loved ones who have fallen ill. Again and again, grieving relatives have testified to how much more devastating their loved one’s death…
Read More
‘Never seen anything as effective’ – the not-so-new-drug repurposed for a rare disease
The earliest signs of alkaptonuria are often subtle and harmless, like a diaper stained black. However, over the years, this rare genetic disease can lead to a lifetime of surgery. Now, after 20 years of research, a not-so-new drug can…
Read More
Dr. Fauci Issues Serious Warning As COVID Infections Decrease
It’s been a while since America has seen the number of COVID-19 cases fall well below the six-figure peak. But while the country is looking at a significant decline in new coronavirus infections, and with The New York Times reporting…
Read More
Germany urges ‘caution’ as COVID infections climb again
German Health Minister Jens Spahn urged caution on Sunday in the face of rising coronavirus infection numbers, just as schools across the country prepare to reopen. “The virus isn’t making it easy for us,” Spahn told German broadcaster ARD. “We’re…
Read More
Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial
A treatment, known as KEDRAB (Rabies Immune Globulin [Human]), currently used in the prevention of rabies has been demonstrated to be safe and effective for patients age 17 and under. Results published today in Human Vaccines & Immunotherapeutics report the…
Read More
FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) as the first immunotherapy treatment indicated for patients with…
Read More